Invention Grant
- Patent Title: Substituted cyclopenta pyrimidine bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
-
Application No.: US15453953Application Date: 2017-03-09
-
Publication No.: US10577377B2Publication Date: 2020-03-03
- Inventor: Aleem Gangjee
- Applicant: Duquesne University of the Holy Spirit
- Applicant Address: US PA Pittsburgh
- Assignee: Duquesne University of The Holy Spirit
- Current Assignee: Duquesne University of The Holy Spirit
- Current Assignee Address: US PA Pittsburgh
- Agency: Buchanan Ingersoll & Rooney PC
- Agent Craig G. Cochenour, Esq.
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61P35/00 ; A61P35/04 ; C07D491/048 ; C07D239/70 ; C07D487/04 ; A61K31/519

Abstract:
The present invention provides substituted cyclopenta and cyclopentyl pyrimidine bicyclic compounds of Formula III, and pharmaceutically acceptable salts, prodrugs, solvates, and hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, such as for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells.
Public/Granted literature
Information query
IPC分类: